Patents Assigned to ID4Pharma, LLC
  • P62-ZZ chemical inhibitor
    Patent number: 11739053
    Abstract: A method for treating a p62-mediated disease (e.g., multiple myeloma) in a subject, the method comprising administering to the subject a therapeutically effective amount of at least one p62-ZZ inhibitor compound.
    Type: Grant
    Filed: March 26, 2019
    Date of Patent: August 29, 2023
    Assignee: ID4PHARMA, LLC
    Inventors: Xiang-Qun Xie, Garson David Roodman, Kyaw-Zeyar Myint, Noriyoshi Kurihara
  • p62-ZZ chemical inhibitor
    Patent number: 9580382
    Abstract: A method for treating a p62-mediated disease (e.g., multiple myeloma) in a subject, the method comprising administering to the subject a therapeutically effective amount of at least one p62-ZZ inhibitor compound.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: February 28, 2017
    Assignee: ID4Pharma, LLC
    Inventors: Xiang-Qun Xie, Garson David Roodman, Kyaw-Zeyar Myint, Noriyoshi Kurihara